Utility of chest ultrasound and intrapleural fibrinolytics with gentamicin following failed pleurodesis

Submitted: October 12, 2024
Accepted: April 14, 2025
Published: May 26, 2025
Abstract Views: 49
PDF_EARLY VIEW: 37
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

This is a case of a 65-year-old male patient who presented to our institution due to worsening dyspnea and respiratory failure development. The patient was admitted due to dyspnea at rest and chest pain. He had a recent medical history of lung cancer with malignant pleural effusion. The patient had already undergone pleural talc poudrage by thoracoscopy, which had not been effective. Indeed, the patient was found to have residual septate pleural effusion on ultrasound examination. A placement of transthoracic pleural drainage followed by intrapleural instillation of urokinase (100,000 units) and gentamicin (80 mg) was performed within 30 days of chemical pleurodesis, achieving re-expansion of the lung by preventing recurrence of the effusion and leading to rapid clinical improvement. The novelty of the present case concerns the effectiveness of a combined treatment of fibrinolytic and intrapleural antibiotic through a pleural drainage after failure of chemical pleurodesis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of lung cancer. Contemp Oncol 2021;25:45-52. DOI: https://doi.org/10.5114/wo.2021.103829
Yang Y, Du J, Wang YS, et al. Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis. Clin Transl Sci 2022;15:1340-54. DOI: https://doi.org/10.1111/cts.13260
Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, et al. Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial. JAMA 2020;323:60-9. DOI: https://doi.org/10.1001/jama.2019.19997
Sharma S, Boster J. Malignant pleural effusion. Treasure Island, FL, USA: StatPearls Publishing; 2024.
Castaldo N, Fantin A, Palou-Schwartzbaum M, et al. Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research. Breathe 2024;20:240002. DOI: https://doi.org/10.1183/20734735.0002-2024
Awadallah SF, Bowling MR, Sharma N, Mohan A. Malignant pleural effusion and cancer of unknown primary site: a review of literature. Ann Transl Med 2019;7:353. DOI: https://doi.org/10.21037/atm.2019.06.33
Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-9. DOI: https://doi.org/10.1016/S0140-6736(07)60708-9
Bellini A, Tarrazzi F, Tami C, et al. Intrapleural fibrinolytic therapy improves results with talc slurry pleurodesis. Cureus 2020;12:e10122. DOI: https://doi.org/10.7759/cureus.10122
Abdul Hamid MF, Hasbullah AHH, Mohamad Jailaini MF, et al. Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion. BMC Pulm Med 2022;22:439. DOI: https://doi.org/10.1186/s12890-022-02239-w
Porcel JM. CT versus thoracic ultrasound for discriminating uncomplicated and complicated parapneumonic pleural effusions - Reply. Respirology 2018;23:232-3. DOI: https://doi.org/10.1111/resp.13203

Ethics Approval

The study was approved by the Ethics Committee of Sapienza University, Sant’Andrea Hospital (n. 656).

How to Cite

Pezzuto, Aldo, Ferdinando Cozzolino, Giosuè Amoroso, Evohe Adone, Elisa Desideri, and Alberto Ricci. 2025. “Utility of Chest Ultrasound and Intrapleural Fibrinolytics With Gentamicin Following Failed Pleurodesis”. Monaldi Archives for Chest Disease, May. https://doi.org/10.4081/monaldi.2025.3224.